326 related articles for article (PubMed ID: 14727987)
1. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
Shlyakhto EV; Almazov VV; Nifontov EM; Vakhrameyeva IV; Rudomanov OG; Zakharov DV; Kazarin VV; Vakhrameyeva NV
Am J Cardiovasc Drugs; 2002; 2(2):119-24. PubMed ID: 14727987
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
Szwed H; Pachocki R; Domzal-Bochenska M; Szymczak K; Szydlowski Z; Paradowski A; Gajos G; Kaluza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
Presse Med; 2000 Mar; 29(10):533-8. PubMed ID: 10761517
[TBL] [Abstract][Full Text] [Related]
3. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
Sellier P; Broustet JP
Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
[TBL] [Abstract][Full Text] [Related]
4. Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study.
Chazov EI; Lepakchin VK; Zharova EA; Fitilev SB; Levin AM; Rumiantzeva EG; Fitileva TB
Am J Ther; 2005; 12(1):35-42. PubMed ID: 15662290
[TBL] [Abstract][Full Text] [Related]
5. Effects of trimetazidine on myocardial perfusion and the contractile response of chronically dysfunctional myocardium in ischemic cardiomyopathy: a 24-month study.
El-Kady T; El-Sabban K; Gabaly M; Sabry A; Abdel-Hady S
Am J Cardiovasc Drugs; 2005; 5(4):271-8. PubMed ID: 15984909
[TBL] [Abstract][Full Text] [Related]
6. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
Belardinelli R
Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
[TBL] [Abstract][Full Text] [Related]
7. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
McClellan KJ; Plosker GL
Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
[TBL] [Abstract][Full Text] [Related]
8. Trimetazidine for stable angina pectoris.
Cross HR
Expert Opin Pharmacother; 2001 May; 2(5):857-75. PubMed ID: 11336628
[TBL] [Abstract][Full Text] [Related]
9. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
Szwed H; Sadowski Z; Elikowski W; Koronkiewicz A; Mamcarz A; Orszulak W; Skibińska E; Szymczak K; Swiatek J; Winter M
Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
[TBL] [Abstract][Full Text] [Related]
10. Combination treatment with trimetazidine and diltiazem in stable angina pectoris.
Manchanda SC; Krishnaswami S
Heart; 1997 Oct; 78(4):353-7. PubMed ID: 9404250
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials.
Peng S; Zhao M; Wan J; Fang Q; Fang D; Li K
Int J Cardiol; 2014 Dec; 177(3):780-5. PubMed ID: 25466565
[TBL] [Abstract][Full Text] [Related]
12. Trimetazidine for stable angina.
Ciapponi A; Pizarro R; Harrison J
Cochrane Database Syst Rev; 2005 Oct; (4):CD003614. PubMed ID: 16235330
[TBL] [Abstract][Full Text] [Related]
13. Real-world Evidence for the Antianginal Efficacy of Trimetazidine from the Russian Observational CHOICE-2 Study.
Glezer M;
Adv Ther; 2017 Apr; 34(4):915-924. PubMed ID: 28220388
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials.
Marzilli M; Klein WW
Coron Artery Dis; 2003 Apr; 14(2):171-9. PubMed ID: 12655281
[TBL] [Abstract][Full Text] [Related]
15. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
16. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
Butina EK; Kokurina EV; Dmitrieva NA; Bochkareva EV
Ter Arkh; 2002; 74(9):36-41. PubMed ID: 12418118
[TBL] [Abstract][Full Text] [Related]
17. WITHDRAWN: Trimetazidine for stable angina.
Ciapponi A; Pizarro R; Harrison J
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD003614. PubMed ID: 28319269
[TBL] [Abstract][Full Text] [Related]
18. Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris.
Frishman WH; Bittar N; Glasser S; Habib G; Smith W; Pordy R
Clin Cardiol; 1998 Jul; 21(7):483-90. PubMed ID: 9669057
[TBL] [Abstract][Full Text] [Related]
19. [Trimetazidine in pectoris patients older than 65 years with stable angina].
Syrkin AL; Lepakhin VK; Fitilev SB; Ivanova EV; Titarova IuIu; Levin AM
Kardiologiia; 2002; 42(6):24-31. PubMed ID: 12494126
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of trimetazidine and diltiazem on exercise performance in patients with coronary heart disease. The Turkish trimetazidine study (TTS).
Koylan N; Bilge AK; Adalet K; Mercanoglu F; Büyüköztürk K;
Acta Cardiol; 2004 Dec; 59(6):644-50. PubMed ID: 15636449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
